Allergy Therapy Reimagined

Our Unique Scientific Approach

Our approach exploits a unique capacity of inactivated mycobacteria to rebalance our immune system and prevent allergic disorders through a long-lasting and safe tolerysing immunoregulatory therapy.

More about our science

Pipeline

As a company dedicated to veterinary and human medicinal products, Tolerys is developing novel biotherapy candidates with important disease modifying effects for the treatment of atopic dermatitis in dogs and humans.

More about our pipeline

Latest News

June 4, 2018

Tolerys launches a Scientific Advisory Board to further broaden its scientific and business expertise.

February 26, 2018

Tolerys was granted an innovation grant from the Office for Economic Affairs (SPECo) of the Canton of Vaud.